S08

Good Clinical Practices

NDCT Rules 2019, ICH E6 GCP, ethics committee, SAE reporting, BA/BE

4.3%
of the paper
≈ 4 marks
#9
by weightage
of 13 topics
50
questions
with explanations
0
cite a provision
Act, Rule or Schedule

Weightage is measured from previous Drug Inspector papers, not estimated. Question counts are read from the live bank when this page is built.

Subtopics in this bank

DSMB roles and responsibilitiesEssential documentsEthics committeesIRB/Ethics Committee scope and boundariesInformed consentInformed consent procedures in GCPInvestigator & sponsor dutiesInvestigator's Brochure content and useLaboratory animal ethicsNDCT Rules 2019Phase II and Phase III trial designProtocol & amendmentsSAE reporting and trial continuance decisionsSAE/AE reporting & compensationSource data verification proceduresTrial phases

Sample questions, with the reasoning

Every question in the bank is explained like this — including why each wrong option is wrong.

A Bioavailability/Bioequivalence (BA/BE) study is defined as a clinical trial that evaluates:

  • A)Only therapeutic efficacy in disease treatment
  • B)The systemic availability of the active drug from a formulation
  • C)Only manufacturing processes without subject participation
  • D)Long-term safety after 5 years of treatment

Why B is correct

BA/BE trials are clinical pharmacology studies where human subjects receive the investigational formulation to measure drug absorption (bioavailability) and compare formulations (bioequivalence).

AI fact-checked

A new drug has completed phase-I clinical trial in USA. The pharmaceutical company wants to do a multicentric, multinational trial including India. The firm will apply in India to conduct

  • A)Phase I-trial
  • B)Phase-II trial
  • C)Pre-clinical trial
  • D)Pharmacokinetic bridging trial

Why D is correct

Under Schedule Y's provisions for global clinical trials, when Phase I has already been completed abroad, India permits participation in the later-phase multinational trial on the strength of a pharmacokinetic bridging study (comparative PK data in the Indian population) rather than repeating a full local Phase I.

AI fact-checked

According to GCP guidelines, the minimum number of members required in the quorum of an Ethics Committee to review a protocol is:

  • A)5
  • B)6
  • C)7
  • D)9

Why A is correct

Indian GCP guidelines require a minimum quorum of 5 members for an Ethics Committee to review a protocol.

AI fact-checked

Practise S08 with real marking

50 questions · −1/3 negative marking · explanations after every answer. No sign-up needed to try.

← All 13 syllabus topics